{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T06:54:26Z","timestamp":1763535266100},"reference-count":70,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"crossref","award":["EY 11224"],"award-info":[{"award-number":["EY 11224"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Edith and Lew Wasserman Endowed Professorship"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.bbapap.2014.02.001","type":"journal-article","created":{"date-parts":[[2014,2,12]],"date-time":"2014-02-12T08:45:21Z","timestamp":1392194721000},"page":"750-758","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Antibacterial activity of rifamycins for M. smegmatis with comparison of oxidation and binding to tear lipocalin"],"prefix":"10.1016","volume":"1844","author":[{"given":"Tamara","family":"Staudinger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"Redl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben J.","family":"Glasgow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbapap.2014.02.001_bb0005","first-page":"237","article-title":"WHO global tuberculosis control report 2010. Summary","volume":"18","year":"2010","journal-title":"Cent. Eur. J. Public Health"},{"key":"10.1016\/j.bbapap.2014.02.001_bb0010","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.tube.2010.02.001","article-title":"Rifamycins\u2014obstacles and opportunities","volume":"90","author":"Aristoff","year":"2010","journal-title":"Tuberculosis (Edinb.)"},{"key":"10.1016\/j.bbapap.2014.02.001_bb0015","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.tube.2010.07.001","article-title":"Re: Review article titled, \u201cRifamycins\u2014obstacles and opportunities\u201d by Paul A. Aristoff, George A. Garcia, Paul D. Kirchhoff, H.D. Hollis Showalter. Tuberculosis 2010; 90(2):94\u2013118","volume":"90","author":"Sayada","year":"2010","journal-title":"Tuberculosis (Edinb.)"},{"key":"10.1016\/j.bbapap.2014.02.001_bb0020","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1111\/j.1365-2958.1990.tb02040.x","article-title":"Isolation and characterization of efficient plasmid transformation mutants of Mycobacterium smegmatis","volume":"4","author":"Snapper","year":"1990","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.bbapap.2014.02.001_bb0025","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1128\/AAC.47.10.3208-3213.2003","article-title":"A rifampin-hypersensitive mutant reveals differences between strains of Mycobacterium smegmatis and presence of a novel transposon, IS1623","volume":"47","author":"Alexander","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbapap.2014.02.001_bb0030","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.tube.2004.11.003","article-title":"Solid lipid particle-based inhalable sustained drug delivery system against experimental tuberculosis","volume":"85","author":"Pandey","year":"2005","journal-title":"Tuberculosis (Edinb.)"},{"key":"10.1016\/j.bbapap.2014.02.001_bb0035","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/10717540801952530","article-title":"Lipid microsphere formulation containing rifampicin targets alveolar macrophages","volume":"15","author":"Takenaga","year":"2008","journal-title":"Drug Deliv."},{"key":"10.1016\/j.bbapap.2014.02.001_bb0040","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1128\/AAC.49.10.4335-4338.2005","article-title":"Oral therapy using nanoparticle-encapsulated antituberculosis drugs in guinea pigs infected with Mycobacterium tuberculosis","volume":"49","author":"Johnson","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbapap.2014.02.001_bb0045","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/jac\/dkl533","article-title":"Uptake of inhalable microparticles affects defence responses of macrophages infected with Mycobacterium tuberculosis H37Ra","volume":"59","author":"Sharma","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bbapap.2014.02.001_bb0050","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1093\/jac\/dkg165","article-title":"Alginate-based oral drug delivery system for tuberculosis: pharmacokinetics and therapeutic effects","volume":"51","author":"Qurrat ul","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bbapap.2014.02.001_bb0055","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/jac\/dkh411","article-title":"Lectin-functionalized poly(lactide-co-glycolide) nanoparticles as oral\/aerosolized antitubercular drug carriers for treatment of tuberculosis","volume":"54","author":"Sharma","year":"2004","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bbapap.2014.02.001_bb0060","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ijpharm.2007.05.062","article-title":"Encapsulation of moxifloxacin within poly(butyl cyanoacrylate) nanoparticles enhances efficacy against intracellular Mycobacterium tuberculosis","volume":"345","author":"Kisich","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bbapap.2014.02.001_bb0065","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijpharm.2009.10.004","article-title":"Gelatin nanocarriers as potential vectors for effective management of tuberculosis","volume":"385","author":"Saraogi","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bbapap.2014.02.001_bb0070","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3109\/1061186X.2010.492522","article-title":"Mannosylated gelatin nanoparticles bearing isoniazid for effective management of tuberculosis","volume":"19","author":"Saraogi","year":"2011","journal-title":"J. Drug Target."},{"key":"10.1016\/j.bbapap.2014.02.001_bb0075","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1128\/AAC.06049-11","article-title":"Targeted intracellular delivery of antituberculosis drugs to Mycobacterium tuberculosis-infected macrophages via functionalized mesoporous silica nanoparticles","volume":"56","author":"Clemens","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbapap.2014.02.001_bb0080","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1167\/iovs.12-10817","article-title":"A novel fluorescent lipid probe for dry eye: retrieval by tear lipocalin in humans","volume":"54","author":"Yeh","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.bbapap.2014.02.001_bb0085","first-page":"547","article-title":"Metal ion catalyzed oxidation of the antibiotic rifampicin","volume":"17","author":"Buss","year":"1977","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"key":"10.1016\/j.bbapap.2014.02.001_bb0090","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.bbadis.2003.11.006","article-title":"Tear lipocalin: potential for selective delivery of rifampin","volume":"1688","author":"Gasymov","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbapap.2014.02.001_bb0095","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1085\/jgp.49.1.29","article-title":"Mechanisms of oxidation with oxygen","volume":"49","author":"Taube","year":"1965","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.bbapap.2014.02.001_bb0100","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.3109\/02713689309029229","article-title":"Assignment of tear lipocalin gene to human chromosome 9q34-9qter","volume":"12","author":"Glasgow","year":"1993","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.bbapap.2014.02.001_bb0105","doi-asserted-by":"crossref","first-page":"20282","DOI":"10.1016\/S0021-9258(19)88698-2","article-title":"cDNA cloning and sequencing reveals human tear prealbumin to be a member of the lipophilic-ligand carrier protein superfamily","volume":"267","author":"Redl","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2014.02.001_bb0110","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/BF00183433","article-title":"Tissue expression of lipocalins in human lacrimal and von Ebner's glands: colocalization with lysozyme","volume":"233","author":"Glasgow","year":"1995","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.bbapap.2014.02.001_bb0115","series-title":"DNA Cloning","article-title":"A Practical Approach","author":"Marston","year":"1987"},{"key":"10.1016\/j.bbapap.2014.02.001_bb0120","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3109\/02713689508999934","article-title":"Tear lipocalins bind a broad array of lipid ligands","volume":"14","author":"Glasgow","year":"1995","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.bbapap.2014.02.001_bb0125","first-page":"683","article-title":"The variable reagent blank: protein determination as a model","volume":"23","author":"Bozimowski","year":"1985","journal-title":"J. Clin. Chem. Clin. Biochem."},{"key":"10.1016\/j.bbapap.2014.02.001_bb0130","first-page":"671","article-title":"The conserved disulfide bond of human tear lipocalin modulates conformation and lipid binding in a ligand selective manner","volume":"2011","author":"Gasymov","year":"1814","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbapap.2014.02.001_bb0135","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.chembiol.2004.08.025","article-title":"Rifampicin inhibits alpha-synuclein fibrillation and disaggregates fibrils","volume":"11","author":"Li","year":"2004","journal-title":"Chem. Biol."},{"key":"10.1016\/j.bbapap.2014.02.001_bb0140","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1086\/317441","article-title":"Susceptibility testing for mycobacteria","volume":"31","author":"Woods","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bbapap.2014.02.001_bb0145","first-page":"18","article-title":"Susceptibility testing of Mycobacteria, Nocardiae, and other aerobic Actinomycetes","volume":"23","author":"Woods","year":"2003"},{"key":"10.1016\/j.bbapap.2014.02.001_bb0150","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.micinf.2005.12.023","article-title":"A role for dendritic cells in the dissemination of mycobacterial infection","volume":"8","author":"Humphreys","year":"2006","journal-title":"Microbes Infect."},{"key":"10.1016\/j.bbapap.2014.02.001_bb0155","series-title":"The Merck Index, an Encyclopedia of Chemicals, Drugs and Biologicals","year":"2001"},{"key":"10.1016\/j.bbapap.2014.02.001_bb0160","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1021\/bi00530a033","article-title":"Rifampicin as a spectroscopic probe of the mechanism of RNA polymerase from Escherichia coli","volume":"21","author":"Reisbig","year":"1982","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbapap.2014.02.001_bb0165","doi-asserted-by":"crossref","first-page":"12067","DOI":"10.1021\/bi030080u","article-title":"Characterization of Mycobacterium tuberculosis mycothiol S-conjugate amidase","volume":"42","author":"Steffek","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbapap.2014.02.001_bb0170","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1128\/JCM.00666-08","article-title":"Rifampin resistance, Beijing-W clade-single nucleotide polymorphism cluster group 2 phylogeny, and the Rv2629 191-C allele in Mycobacterium tuberculosis strains","volume":"46","author":"Chakravorty","year":"2008","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.bbapap.2014.02.001_bb0175","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/jac\/45.2.159","article-title":"Accumulation of rifampicin by Mycobacterium aurum, Mycobacterium smegmatis and Mycobacterium tuberculosis","volume":"45","author":"Piddock","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bbapap.2014.02.001_bb0180","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1128\/AAC.50.1.250-255.2006","article-title":"AsnB is involved in natural resistance of Mycobacterium smegmatis to multiple drugs","volume":"50","author":"Ren","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbapap.2014.02.001_bb0185","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1128\/AAC.00239-08","article-title":"Role of porins for uptake of antibiotics by Mycobacterium smegmatis","volume":"52","author":"Danilchanka","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbapap.2014.02.001_bb0190","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1073\/pnas.96.7.4011","article-title":"A mutant of Mycobacterium smegmatis defective in the biosynthesis of mycolic acids accumulates meromycolates","volume":"96","author":"Liu","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbapap.2014.02.001_bb0195","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/jac\/22.2.185","article-title":"Intraphagocytic penetration of antibiotics","volume":"22","author":"Van der Auwera","year":"1988","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bbapap.2014.02.001_bb0200","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1128\/AAC.39.10.2295","article-title":"In vitro and in vivo activities of the benzoxazinorifamycin KRM-1648 against Mycobacterium tuberculosis","volume":"39","author":"Hirata","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbapap.2014.02.001_bb0205","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1128\/AAC.40.2.426","article-title":"In vitro bactericidal and in vivo therapeutic activities of a new rifamycin derivative, KRM-1648, against Mycobacterium tuberculosis","volume":"40","author":"Yamamoto","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbapap.2014.02.001_bb0210","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1021\/jm00330a013","article-title":"Rifamycins. XLI. A new class of active semisynthetic rifamycins. N-substituted aminomethyl derivatives of rifamycin SV 2","volume":"8","author":"Maggi","year":"1965","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbapap.2014.02.001_bb0215","first-page":"765","article-title":"New derivatives of rifamycin SV","volume":"5","author":"Maggi","year":"1965","journal-title":"Antimicrob. Agents Chemother. (Bethesda)"},{"key":"10.1016\/j.bbapap.2014.02.001_bb0220","first-page":"699","article-title":"Chemical modifications and biological properties of rifamycins","volume":"6","author":"Sensi","year":"1966","journal-title":"Antimicrob. Agents Chemother. (Bethesda)"},{"key":"10.1016\/j.bbapap.2014.02.001_bb0225","doi-asserted-by":"crossref","first-page":"6094","DOI":"10.1016\/j.bmcl.2011.08.054","article-title":"Synthesis and structure\u2013activity relationships of novel substituted 8-amino, 8-thio, and 1,8-pyrazole congeners of antitubercular rifamycin S and rifampin","volume":"21","author":"Jin","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbapap.2014.02.001_bb0230","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.tube.2011.05.002","article-title":"Rifamycin inhibition of WT and Rif-resistant Mycobacterium tuberculosis and Escherichia coli RNA polymerases in vitro","volume":"91","author":"Gill","year":"2011","journal-title":"Tuberculosis (Edinb.)"},{"key":"10.1016\/j.bbapap.2014.02.001_bb0235","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/00498257609151608","article-title":"Implication of rifampicin-quinone in the irreversible binding of rifampicin to macromolecules","volume":"6","author":"Bolt","year":"1976","journal-title":"Xenobiotica"},{"key":"10.1016\/j.bbapap.2014.02.001_bb0240","doi-asserted-by":"crossref","first-page":"7219","DOI":"10.1021\/bi9005557","article-title":"Intracavitary ligand distribution in tear lipocalin by site-directed tryptophan fluorescence","volume":"48","author":"Gasymov","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbapap.2014.02.001_bb0245","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1107\/S0907444909031011","article-title":"A new crystal form of human tear lipocalin reveals high flexibility in the loop region and induced fit in the ligand cavity","volume":"65","author":"Breustedt","year":"2009","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.bbapap.2014.02.001_bb0250","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1076\/ceyr.21.4.824.5551","article-title":"Functional cavity dimensions of tear lipocalin","volume":"21","author":"Abduragimov","year":"2000","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.bbapap.2014.02.001_bb0255","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.abb.2007.09.011","article-title":"Evidence for internal and external binding sites on human tear lipocalin","volume":"468","author":"Gasymov","year":"2007","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbapap.2014.02.001_bb0260","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1021\/bi701955e","article-title":"Ligand binding site of tear lipocalin: contribution of a trigonal cluster of charged residues probed by 8-anilino-1-naphthalenesulfonic acid","volume":"47","author":"Gasymov","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbapap.2014.02.001_bb0265","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1074\/jbc.M410466200","article-title":"The 1.8-A crystal structure of human tear lipocalin reveals an extended branched cavity with capacity for multiple ligands","volume":"280","author":"Breustedt","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbapap.2014.02.001_bb0270","doi-asserted-by":"crossref","first-page":"14754","DOI":"10.1021\/bi0110342","article-title":"Site-directed tryptophan fluorescence reveals the solution structure of tear lipocalin: evidence for features that confer promiscuity in ligand binding","volume":"40","author":"Gasymov","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbapap.2014.02.001_bb0275","doi-asserted-by":"crossref","first-page":"17128","DOI":"10.1021\/jp1097487","article-title":"What is solvatochromism?","volume":"114","author":"Marini","year":"2010","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.bbapap.2014.02.001_bb0280","doi-asserted-by":"crossref","first-page":"13707","DOI":"10.1021\/bi9913449","article-title":"Side chain mobility and ligand interactions of the G strand of tear lipocalins by site-directed spin labeling","volume":"38","author":"Glasgow","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbapap.2014.02.001_bb0285","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.tube.2011.12.004","article-title":"Genetic variants in antioxidant pathway: risk factors for hepatotoxicity in tuberculosis patients","volume":"92","author":"Nanashima","year":"2012","journal-title":"Tuberculosis (Edinb.)"},{"key":"10.1016\/j.bbapap.2014.02.001_bb0290","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.bcp.2011.08.003","article-title":"Human arylacetamide deacetylase is responsible for deacetylation of rifamycins: rifampicin, rifabutin, and rifapentine","volume":"82","author":"Nakajima","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbapap.2014.02.001_bb0295","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0009-9120(95)02024-1","article-title":"In vitro protein binding characteristics of isoniazid, rifampicin, and pyrazinamide to whole plasma, albumin, and alpha-1-acid glycoprotein","volume":"29","author":"Woo","year":"1996","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.bbapap.2014.02.001_bb0300","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0378-4347(00)81972-6","article-title":"Determination of rifampicin and its main metabolites in human plasma by high-performance liquid chromatography","volume":"426","author":"Ishii","year":"1988","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.bbapap.2014.02.001_bb0305","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/jac\/dki069","article-title":"Analysis of rpoB and pncA mutations in the published literature: an insight into the role of oxidative stress in Mycobacterium tuberculosis evolution?","volume":"55","author":"O'Sullivan","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bbapap.2014.02.001_bb0310","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1128\/AAC.45.7.1972-1976.2001","article-title":"Safety and bactericidal activity of rifalazil in patients with pulmonary tuberculosis","volume":"45","author":"Dietze","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbapap.2014.02.001_bb0315","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1080\/004982598239173","article-title":"Effect of a new rifamycin derivative, rifalazil, on liver microsomal enzyme induction in rat and dog","volume":"28","author":"Mae","year":"1998","journal-title":"Xenobiotica"},{"key":"10.1016\/j.bbapap.2014.02.001_bb0320","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2165\/00003088-200140050-00002","article-title":"Comparative pharmacokinetics and pharmacodynamics of the rifamycin antibacterials","volume":"40","author":"Burman","year":"2001","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.bbapap.2014.02.001_bb0325","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1128\/AAC.40.12.2749","article-title":"Pharmacokinetics of KRM-1648, a new benzoxazinorifamycin, in rats and dogs","volume":"40","author":"Hosoe","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbapap.2014.02.001_bb0330","doi-asserted-by":"crossref","first-page":"e83232","DOI":"10.1371\/journal.pone.0083232","article-title":"First-in-human phase i Study of PRS-050 (Angiocal), an anticalin targeting and antagonizing VEGF-A, in patients with advanced solid tumors","volume":"8","author":"Mross","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbapap.2014.02.001_bb0335","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1128\/JCM.24.6.1060-1070.1986","article-title":"Determination of molecular species composition of C80 or longer-chain alpha-mycolic acids in Mycobacterium spp. by gas chromatography\u2013mass spectrometry and mass chromatography","volume":"24","author":"Kaneda","year":"1986","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.bbapap.2014.02.001_bb0340","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/oxfordjournals.jbchem.a122825","article-title":"Thermally adaptive changes of mycolic acids in Mycobacterium smegmatis","volume":"106","author":"Baba","year":"1989","journal-title":"J. Biochem."},{"key":"10.1016\/j.bbapap.2014.02.001_bb0345","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0167-4838(99)00133-8","article-title":"Binding studies of tear lipocalin: the role of the conserved tryptophan in maintaining structure, stability and ligand affinity","volume":"1433","author":"Gasymov","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbapap.2014.02.001_bb0350","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1086\/650493","article-title":"Intracellular Mycobacterium avium intersect transferrin in the Rab11(+) recycling endocytic pathway and avoid lipocalin 2 trafficking to the lysosomal pathway","volume":"201","author":"Halaas","year":"2010","journal-title":"J. Infect. Dis."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570963914000223?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570963914000223?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,26]],"date-time":"2022-03-26T10:44:39Z","timestamp":1648291479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570963914000223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":70,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S1570963914000223"],"URL":"https:\/\/doi.org\/10.1016\/j.bbapap.2014.02.001","relation":{},"ISSN":["1570-9639"],"issn-type":[{"value":"1570-9639","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibacterial activity of rifamycins for M. smegmatis with comparison of oxidation and binding to tear lipocalin","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbapap.2014.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}